Physician profile
Rebecca Stack
NPI 1164955746
$14,965.62
in general payments reported to CMS, 2019-2025
29 companies · $3,146 in 2025
The $3,146 reported for 2025 was more than what 90% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $912 · 2021: $1,571 · 2022: $2,720 · 2023: $2,189 · 2024: $4,306 · 2025: $3,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,377 · Travel and Lodging: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,377.10 |
| Travel and Lodging | $1,264.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,256.67 | 2020-2025 | Inbone, Citrefix, Ortholoc 2 Lapifuse |
| Kerecis Limited | $3,543.77 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Surgenex LLC | $673.90 | 2025 | Renograft, Surgraft, Ardeograft |
| Fusion Orthopedics USA, LLC | $447.49 | 2023-2025 | |
| Depuy Synthes Sales INC. | $363.01 | 2020-2025 | Motoband, Healix Knotless Peek, Dynacord |
| Treace Medical Concepts, INC. | $353.05 | 2023-2025 | |
| Medela LLC | $287.69 | 2021-2023 | Invia Motion Endure |
| Boston Scientific Corporation | $247.52 | 2019-2025 | Jetstream Sc |
| Linvatec Corporation | $155.20 | 2024 | Biobrace 23mm, Fracture and Correction Colag 2 |
| Anika Therapeutics, INC. | $153.34 | 2024 | Sports Medicine |
| Bone Support INC. | $140.71 | 2025 | Cerament G, Ceramentbone Void Filler |
| Medtronic, INC. | $128.06 | 2022 | |
| Smith+Nephew, INC. | $127.28 | 2021 | |
| Melinta Therapeutics, LLC | $125.00 | 2021 | |
| Flower Orthopedics Coporation | $124.28 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $124.16 | 2023 | Prolia |
| Biotissue Holdings INC. | $122.01 | 2022 | |
| Paragon 28, INC. | $119.45 | 2020-2024 | Ankle Fracture |
| Baudax Bio INC. | $108.02 | 2020 | |
| Acera Surgical, INC. | $50.97 | 2020-2022 | |
| Misonix INC | $48.09 | 2020 | |
| Biocomposites INC | $45.45 | 2021 | |
| Abbott Laboratories | $45.45 | 2022 | |
| Osteomed LLC | $44.96 | 2021 | |
| Acumed LLC | $36.45 | 2023 | Osteomed, Acumed |
| Horizon Therapeutics Plc | $30.68 | 2020-2023 | Krystexxa |
| Arteriocyte Medical Systems, INC. | $28.54 | 2020 | |
| Paratek Pharmaceuticals, INC. | $23.31 | 2021 | |
| Celularity INC. | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Stack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.